Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

Procainamide hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for procainamide hydrochloride and what is the scope of procainamide hydrochloride freedom to operate?

Procainamide hydrochloride
is the generic ingredient in seven branded drugs marketed by Parke Davis, Watson Labs, Ivax Sub Teva Pharms, Parkedale, Ani Pharms Inc, Abraxis Pharm, Idt Australia Ltd, Pharmafair, Warner Chilcott, West-ward Pharms Int, Smith And Nephew, Solopak, Apothecon, Intl Medication, Hospira, Inwood Labs, Ascot, Lederle, Vangard, King Pharms, Panray, Sandoz, Roxane, and Lannett, and is included in seventy-three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for procainamide hydrochloride. Four suppliers are listed for this compound.

Summary for Generic Name: procainamide hydrochloride

Drug Master File Entries: see list8
Suppliers / Packagers: see list4
Bulk Api Vendors: see list55
Clinical Trials: see list990
Patent Applications: see list1,519
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:procainamide hydrochloride at DailyMed

Pharmacology for Ingredient: procainamide hydrochloride

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
procainamide hydrochloride
CAPSULE;ORAL086952-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
procainamide hydrochloride
INJECTABLE;INJECTION089029-001Apr 17, 1986DISCNNoNo► Subscribe► Subscribe
Smith And Nephew
procainamide hydrochloride
INJECTABLE;INJECTION088530-001Mar 4, 1985DISCNNoNo► Subscribe► Subscribe
procainamide hydrochloride
TABLET, EXTENDED RELEASE;ORAL087361-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Abraxis Pharm
procainamide hydrochloride
INJECTABLE;INJECTION089415-001Nov 17, 1986DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus